Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13Lung Neoplasms 2Esophageal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sjogren's Syndrome 1Scleroderma, Systemic 1Retinoblastoma 1Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1Resectable Non-small Cell Lung Cancer 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Psoriasis 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Sclerosis 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Dermatomyositis 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Ovarian Epithelial 1Carcinoma, Bronchogenic 1Bronchial Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Advanced Non-small Cell Lung Cancer 1

Interventions

Specimen Handling 2nedaplatin 1X-Rays 1Relaxation Therapy 1Protons 1Proton Therapy 1Platinum Compounds 1Physical Therapy Modalities 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Resectable Lung Non-Small Cell Carcinoma × Platinum Compounds × Clear all
NCT06775275 2025-01-15

A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting
60 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡